Werewolf Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. 

CEO
Daniel J. Hicklin
CEODaniel J. Hicklin
Employees
46
Employees46
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2017
Founded2017
Employees
46
Employees46

HOWL Key Statistics

Market cap
37.94M
Market cap37.94M
Price-Earnings ratio
-0.48
Price-Earnings ratio-0.48
Dividend yield
Dividend yield
Average volume
300.38K
Average volume300.38K
High today
$0.8003
High today$0.8003
Low today
$0.7624
Low today$0.7624
Open price
$0.7958
Open price$0.7958
Volume
178.56K
Volume178.56K
52 Week high
$2.38
52 Week high$2.38
52 Week low
$0.5301
52 Week low$0.5301

Stock Snapshot

The current Werewolf Therapeutics(HOWL) stock price is $0.78, with a market capitalization of 37.94M. The stock trades at a price-to-earnings (P/E) ratio of -0.48.

During the trading session on 2026-03-25, Werewolf Therapeutics(HOWL) shares reached a daily high of $0.80 and a low of $0.76. At a current price of $0.78, the stock is +2.3% higher than the low and still -2.5% under the high.

Trading volume for Werewolf Therapeutics(HOWL) stock has reached 178.56K, versus its average volume of 300.38K.

The stock's 52-week range extends from a low of $0.53 to a high of $2.38.

The stock's 52-week range extends from a low of $0.53 to a high of $2.38.

People also own

Based on the portfolios of people who own HOWL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.